Active stents in diabetic patients

Diabetes & Metabolism - Tập 31 - Trang 387-390 - 2005
G Drobinski, C Le Feuvre

Tài liệu tham khảo

Kelsey, 1999, Patients with diabetes did better with coronary bypass graft surgery than with percutaneous transluminal coronary angioplasty: was this BARI finding real?, Am Heart J, 138, S387, 10.1016/S0002-8703(99)70040-2 King, 2000, Eight-year mortality in the Emory Angioplasty versus Surgery Trial (EAST), J Am Coll Cardiol, 35, 1116, 10.1016/S0735-1097(00)00546-5 Kurbaan, 2001, Difference in the mortality of the CABRI diabetic and nondiabetic populations and its relation to coronary artery disease and the revascularization mode, Am J Cardiol, 87, 947, 10.1016/S0002-9149(01)01426-6 Morice, 2002, A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization, N Engl J Med, 346, 1773, 10.1056/NEJMoa012843 Regar, 2002, Angiographic findings of the multicenter Randomized Study With the Sirolimus-Eluting Bx Velocity Balloon-Expandable Stent (RAVEL): sirolimus-eluting stents inhibit restenosis irrespective of the vessel size, Circulation, 106, 1949, 10.1161/01.CIR.0000034045.36219.12 Moussa, 2004, Impact of sirolimus-eluting stents on outcome in diabetic patients: a SIRIUS (SIRolImUS-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo coronary lesions) substudy, Circulation, 109, 2273, 10.1161/01.CIR.0000129767.45513.71 Bullesfeld, 2003, Long-term evaluation of paclitaxel-coated stents for treatment of native coronary lesions. First results of both the clinical and angiographic 18 month follow-up of TAXUS I, Z Kardiol, 92, 825, 10.1007/s00392-003-0971-y Tanabe, 2004, Chronic arterial responses to polymer-controlled paclitaxel-eluting stents: comparison with bare metal stents by serial intravascular ultrasound analyses: data from the randomized TAXUS-II trial, Circulation, 109, 196, 10.1161/01.CIR.0000109137.51122.49 Tanabe, 2003, TAXUS III trial: in-stent restenosis treated with stent-based delivery of paclitaxel incorporated in a slow-release polymer formulation, Circulation, 107, 559, 10.1161/01.CIR.0000048184.96491.8A Choi SH. Presented at the American Diabetes Association 63rd Scientific Session, New Orleans, June 2003